NEW YORK — Intel’s stock suffered its worst single-day collapse since Richard Nixon was in the White House on October 30, shedding 28.58% to close at $65.76 — a number that, just four months ago, would have seemed inconceivable for a company trading above $142.
How Intel Got Here: A Recovery Story That Just Hit a Wall
Intel entered 2026 as one of the most compelling turnaround narratives in the semiconductor sector. After bottoming near $32.89 in late November 2025, the stock had rallied nearly 100% by June, fueled by credible progress on its foundry ambitions, an improving data center business, and the broader AI infrastructure boom lifting all chipmakers. The recovery looked durable. Then came October 29.
The company’s Q3 2026 earnings report initially appeared solid on its face. Non-GAAP EPS of $0.52 beat the consensus estimate of $0.41 by nearly 28%. Revenue of $16.51 billion grew 21% year-over-year. The Data Center and AI segment — DCAI — posted revenue of $7.3 billion, up 17% sequentially and nearly 80% year-over-year, the strongest segment growth Intel has seen in 15 years. For about six hours, it looked like Intel had delivered.
Then the guidance landed. As we examined in real time last week, Intel’s Q4 outlook was not a modest miss. The company forecast revenue of $15.0–$16.0 billion for the fourth quarter — a sequential decline from Q3’s $16.51 billion — and non-GAAP EPS of just $0.25, a figure that left analysts visibly stunned. The prior consensus had been sitting at $0.44 EPS and $17.10 billion in revenue. The gap between what Wall Street expected and what Intel delivered on guidance was not rounding error — it was a structural reassessment.
The Fab 28 Problem — and What It Doesn’t Explain
Intel disclosed that an incident at its Fab 28 fabrication facility in Israel will cost the company approximately $300 million in Q4 revenue and 200 basis points of gross margin. That is a material hit, and the market rightly priced it in. But here is what the sell-side didn’t miss: $300 million in revenue doesn’t fully account for the midpoint of Intel’s Q4 guidance coming in more than $1.5 billion below the prior consensus. The fab incident is the visible tip; something below the waterline is also moving.
Intel’s Consumer Client Products Group — CCPG — posted revenue of $8.1 billion in Q3, already down 9% sequentially and below expectations. The PC market has been unable to generate the sustained upgrade cycle that Intel needs to backstop its foundry transition. While DCAI is accelerating, CCPG remains a drag that no amount of AI enthusiasm has been able to fully offset. That structural mismatch between Intel’s two core engines is the story the guidance numbers are telling.
Where the Broader Market Sat When Intel Fell
Intel’s collapse didn’t happen in a vacuum. The Nasdaq Composite fell 2.86% on October 30 to close at 25,437, and the S&P 500 dropped 1.82% to 7,580. As our analysis of the chip sector rout showed, the damage radiated outward — semiconductor-adjacent names sold off as traders questioned whether Intel’s guidance miss signaled a broader deceleration in enterprise AI infrastructure spending or was specific to Intel’s execution problems.
The honest answer is probably both. Intel has company-specific issues: the fab transition, the CCPG weakness, and now a physical facility incident. But any company forecasting a sequential revenue decline in Q4 against a backdrop of surging AI capex raises a legitimate question — if enterprise customers are spending heavily on chips, why isn’t Intel capturing more of it? That question stings more than the guidance miss itself, and it likely explains why the market reaction was so severe even after a headline beat.
What the Analysts Said — and What They Stopped Saying
The analyst response on October 30 was swift and largely unified in direction, if not magnitude. Bank of America Securities downgraded Intel from Buy to Neutral and slashed its price target from $145 to $100 — one of the most dramatic reversals of the day given how bullish the firm had been. Roth Capital moved to Neutral from Buy as well, cutting its target from $120 to $70, a number that now sits just 6.5% above Friday’s close. Seaport Research downgraded to Neutral and declined to set a price target at all, citing the absence of visibility — which is itself a signal worth taking seriously.
Other notable cuts: Susquehanna trimmed to $75 from $105 while maintaining Neutral. Goldman Sachs, already at Neutral, reduced its target by one-third to $100. Morgan Stanley lowered to $75 from $84. RBC Capital moved to $75 from $100. TD Cowen went to $75 from $95. Truist Financial dropped its objective from $108 to $72. The blended consensus target now sits near $97.93, implying 48.9% upside from current levels — but consensus targets measured the day after a 29% crash are notoriously unreliable guides, as firms are still calibrating how much their models need to change.
The overall rating distribution — 2 Strong Buy, 20 Buy, 26 Hold, 2 Sell — still leans constructive in aggregate. That constructive tilt, however, reflects where analysts were positioned before October 29, not where a clean-slate assessment would put them today. Expect further target reductions as firms update their full models over the coming two weeks. The 2027 EPS consensus of $2.04 — already revised up from $1.51 ninety days ago — is now under active review across desks.
It’s also worth asking a harder question that Wall Street has been reluctant to pose directly: if Intel’s DCAI segment is genuinely growing at 80% year-over-year, why isn’t the company generating enough cash to absorb a $300 million fab incident without blowing its entire Q4 EPS? The answer involves the capital-intensive reality of running a leading-edge foundry business simultaneously with product development. Intel is trying to do what no American company has done in a generation — rebuild domestic semiconductor manufacturing capacity from the middle of the income statement. That ambition has a price, and Q4 guidance is part of it.
For broader context on how this earnings period is reshaping the tech trade, see our coverage of Alphabet’s search miss and what it signals for AI monetization and our weekend look at whether Apple and the jobs report can arrest a three-week slide.
The Levels That Will Define the Next Chapter
Intel’s technical picture is unambiguous in the near term: the stock is broken. Both the 50-day moving average at $101.10 and the 200-day moving average at $86.36 are now far above Friday’s close. The stock closed below both averages in a single session — that’s not a pullback, that’s a reset. The question is whether $64.11 — Friday’s intraday low — holds as a near-term floor, or whether next week’s trading finds the market still in price discovery mode on what Intel is actually worth post-guidance.
The 2027 EPS consensus of $2.04, even at the low end of $1.56, would put INTC at roughly 42x forward earnings at current prices. That is not cheap for a company guiding to $0.25 non-GAAP EPS in Q4. The bull case requires believing that Q4 is the trough — that the Fab 28 issue is non-recurring, that CCPG stabilizes, and that DCAI’s 80% growth rate sustains long enough to change the earnings trajectory materially by mid-2027. That is a coherent thesis. It is not, however, a low-risk one.
| Level / Event | Value | Signal |
|---|---|---|
| Friday intraday low | $64.11 | Near-term floor; a weekly close below this level removes last visible support and opens a path to the mid-$50s |
| 200-day moving average | $86.36 | Recapturing this level within 6 weeks would signal institutional re-accumulation and a credible thesis reset |
| 50-day moving average | $101.10 | Longer-term recovery target; unlikely to be tested before Q4 earnings in late January unless guidance is revised upward |
| Analyst consensus target | $97.93 | Implies 48.9% upside but is actively being revised lower; treat as a ceiling, not a magnet, until Q4 reports |
| Q4 2026 earnings report | Late Jan 2027 | The definitive reset catalyst; Fab 28 recovery progress and DCAI momentum will determine whether Q4 was the floor or a plateau |
Intel at $65.76 is not the same company that traded at $142.35 in June. The guidance miss, the fab incident, and the sequential decline in CCPG have genuinely reset the earnings power assumption for the next two quarters. Whether the stock at this level is cheap or still expensive depends entirely on a question that cannot yet be answered: how fast can DCAI’s growth rate compensate for everything else? Until that answer becomes visible in actual results — not management commentary, not analyst models — the stock remains in a zone where the downside is as plausible as the upside. Intel’s foundry ambitions remain a generational bet on American chip manufacturing. Generational bets, by definition, don’t resolve in a single quarter.
This article is published by PreMarket Daily for informational purposes only. Nothing here constitutes financial advice, investment recommendations, or an offer to buy or sell any securities. Always consult a qualified financial professional before making investment decisions.
No Comment! Be the first one.